Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug-Eluting Stents | 2 | 2014 | 14 | 0.740 |
Why?
|
| Prosthesis Failure | 2 | 2014 | 50 | 0.670 |
Why?
|
| Anticoagulants | 2 | 2019 | 122 | 0.650 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2018 | 79 | 0.610 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 8 | 0.550 |
Why?
|
| Stroke | 4 | 2019 | 691 | 0.550 |
Why?
|
| Secondary Prevention | 1 | 2018 | 73 | 0.540 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 28 | 0.430 |
Why?
|
| Device Removal | 1 | 2014 | 39 | 0.430 |
Why?
|
| Stents | 3 | 2003 | 159 | 0.390 |
Why?
|
| Catheterization | 2 | 2009 | 55 | 0.340 |
Why?
|
| Coronary Thrombosis | 1 | 2009 | 12 | 0.310 |
Why?
|
| Endocarditis | 2 | 2020 | 22 | 0.300 |
Why?
|
| Patient Selection | 2 | 2008 | 272 | 0.300 |
Why?
|
| Heart Valve Prosthesis | 2 | 2007 | 58 | 0.300 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 8 | 0.290 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2003 | 61 | 0.280 |
Why?
|
| Aortic Valve | 1 | 2007 | 58 | 0.260 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 46 | 0.260 |
Why?
|
| Aortic Valve Stenosis | 1 | 2007 | 40 | 0.260 |
Why?
|
| Palliative Care | 1 | 2007 | 51 | 0.250 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 28 | 0.250 |
Why?
|
| Angioplasty | 2 | 2004 | 29 | 0.250 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 427 | 0.240 |
Why?
|
| Carotid Stenosis | 2 | 2003 | 59 | 0.230 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 465 | 0.230 |
Why?
|
| Treatment Outcome | 8 | 2018 | 3416 | 0.220 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2009 | 34 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.210 |
Why?
|
| Time Factors | 4 | 2018 | 2204 | 0.200 |
Why?
|
| Humans | 20 | 2020 | 32274 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Risk Assessment | 3 | 2018 | 1425 | 0.190 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2003 | 14 | 0.190 |
Why?
|
| Dissection | 1 | 2003 | 16 | 0.190 |
Why?
|
| Tyrosine | 1 | 2003 | 24 | 0.190 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 34 | 0.190 |
Why?
|
| Aortic Diseases | 1 | 2003 | 62 | 0.180 |
Why?
|
| Peptides | 1 | 2003 | 127 | 0.180 |
Why?
|
| Quality of Life | 1 | 2007 | 964 | 0.180 |
Why?
|
| Aging | 1 | 2007 | 942 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 245 | 0.170 |
Why?
|
| Aged | 11 | 2020 | 10260 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Radiography | 2 | 2014 | 362 | 0.170 |
Why?
|
| Female | 13 | 2020 | 19942 | 0.160 |
Why?
|
| Middle Aged | 11 | 2020 | 11848 | 0.160 |
Why?
|
| Male | 12 | 2020 | 19437 | 0.160 |
Why?
|
| Drug Users | 1 | 2020 | 15 | 0.160 |
Why?
|
| Injections | 1 | 2020 | 72 | 0.150 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 34 | 0.150 |
Why?
|
| Adult | 7 | 2020 | 9256 | 0.140 |
Why?
|
| Risk Factors | 3 | 2018 | 3934 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2003 | 823 | 0.130 |
Why?
|
| Recurrence | 1 | 2018 | 285 | 0.130 |
Why?
|
| Renal Artery Obstruction | 2 | 2008 | 38 | 0.130 |
Why?
|
| Hospitalization | 1 | 2020 | 475 | 0.130 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 31 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 541 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 853 | 0.120 |
Why?
|
| Coronary Disease | 2 | 2007 | 226 | 0.110 |
Why?
|
| Coronary Restenosis | 1 | 2014 | 15 | 0.110 |
Why?
|
| North Carolina | 3 | 2020 | 1300 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2016 | 854 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2020 | 3624 | 0.080 |
Why?
|
| Fluoroscopy | 1 | 2009 | 36 | 0.070 |
Why?
|
| Femoral Artery | 1 | 2009 | 45 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2009 | 57 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 124 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 178 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 3898 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2007 | 106 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2007 | 51 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 46 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2008 | 666 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2008 | 393 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 555 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 186 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 395 | 0.060 |
Why?
|
| Infant | 1 | 2008 | 1010 | 0.060 |
Why?
|
| Leg | 1 | 2005 | 67 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 51 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2008 | 1233 | 0.060 |
Why?
|
| Middle Cerebral Artery | 1 | 2004 | 13 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1179 | 0.050 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 37 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2003 | 22 | 0.050 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2003 | 51 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 46 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 65 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2003 | 82 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2008 | 820 | 0.050 |
Why?
|
| Child | 1 | 2008 | 2434 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 1840 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2020 | 28 | 0.040 |
Why?
|
| Heart Failure | 1 | 2005 | 728 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2009 | 2316 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2648 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 2240 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 1158 | 0.020 |
Why?
|
| Palpation | 1 | 2009 | 9 | 0.020 |
Why?
|
| Hematoma | 1 | 2009 | 26 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 76 | 0.020 |
Why?
|
| American Heart Association | 1 | 2008 | 92 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 757 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 86 | 0.020 |
Why?
|
| Argentina | 1 | 2005 | 5 | 0.010 |
Why?
|
| Germany | 1 | 2005 | 6 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2007 | 565 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 1241 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 553 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 96 | 0.010 |
Why?
|
| Diastole | 1 | 2005 | 98 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 273 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 591 | 0.010 |
Why?
|
| Patient Admission | 1 | 2005 | 54 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 159 | 0.010 |
Why?
|
| Ischemia | 1 | 2005 | 115 | 0.010 |
Why?
|
| Retreatment | 1 | 2004 | 42 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 262 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 651 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2004 | 63 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 165 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2003 | 23 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 92 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 955 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2005 | 417 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 861 | 0.010 |
Why?
|
| United States | 1 | 2008 | 4072 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 907 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 8199 | 0.010 |
Why?
|